A small study published in Gynecologic Oncology Reports last week found that 71% of gynecological cancer patients reported self-improvement while consuming medical cannabis of at least one symptom, with 15% of patients stopping use because of the side effects.
45 patients with an average age of 60 years took part in the study. The study was conducted by researchers from New York University’s Mother-of-Pearl Cancer Center, the State University of New York Downstate Health Sciences University, and the New York University Grossman School of Medicine.
Overall, 56% of patients used medicinal cannabis for pain, 47% for nausea and vomiting, 33% for anorexia, and 27% for insomnia. More than 70% of patients reported an improvement in nausea and vomiting, with 36% of patients finding relief from their pain from medical cannabis.
“In this limited cohort of gynecological oncology patients, medical marijuana was effective in relieving nausea / vomiting, anorexia, and insomnia in the majority of patients, but was less helpful in managing pain.” June 2021
Approximately 55% of the patients participating in the study were prescribed formulations with a THC: CBD ratio of 1: 1. Inhaled and sublingual formulations were prescribed for more than 70% of patients, and some were prescribed more than one formulation, which, according to the researchers, limited their “ability to comment on the effectiveness of certain THC: CBD ratios or supplements for certain symptoms”. The researchers also found that they “did not explicitly exclude patients who used recreational marijuana”.
Exclusive offer from our sponsor:
Get daily news insights into your inbox. Subscribe to
TG joined Ganjapreneur in 2014 as a news writer and began hosting the Ganjapreneur podcast in 2016. He lives in New York State, where he also teaches media studies at a local university.